Disclosed are compounds of formula (I):
wherein R1 and R4 are defined herein, which are useful as inhibitors of the kinase activity of the IκB kinase (IKK) complex. The compounds are therefore useful in the treatment of IKK mediated diseases including autoimmune diseases inflammatory diseases, cardiovascular disease and cancer. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.
本发明涉及化合物(I)的公开,其中R1和R4在此定义,该化合物可用作IκB激酶(IKK)复合物的激酶活性
抑制剂。因此,这些化合物可用于治疗由IKK介导的疾病,包括自身免疫性疾病、炎症性疾病、心血管疾病和癌症。还公开了包含这些化合物的制药组合物以及制备这些化合物的方法。